Cryo-Cell International, Inc. (CCEL) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cryo-Cell International, Inc. on September 13, 2024. The filing serves to notify stockholders of the scheduling of the company's 2024 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
There are no material changes to financial operations or business strategy reported in this document. The primary event is the administrative scheduling of the Annual Meeting.
Guidance, Outlook, and Management Commentary
Management has announced the following key dates for the 2024 Annual Meeting:
- Meeting Date: October 29, 2024
- Record Date: September 20, 2024 (for determining stockholders entitled to notice and vote)
- Deadline for Stockholder Proposals: Stockholders intending to present business or director nominations must submit notice no later than the 10th calendar day following September 17, 2024 (the date of public disclosure).
The filing references the Company's Bylaws for specific submission requirements regarding business proposals and director nominations.
Key Facts for Investor Verification
- Verify the record date of September 20, 2024, to confirm eligibility to vote at the Annual Meeting.
- Confirm the deadline for submitting stockholder proposals, which is calculated based on the September 17, 2024 public disclosure date.
- Note that this filing contains no financial results; investors should refer to the most recent 10-Q or 10-K for financial data.